JPRN-UMIN000006242RecruitingPhase 2
A Phase II study of preoperative concurrent chemoradiotherapy with TS-1 in patients with locally advanced lower rectal cancer. - A Phase II study of preoperative concurrent chemoradiotherapy with TS-1 in patients with locally advanced lower rectal cancer. (PRESENTER)
ara Hospital Kinki University Faculty of Medicine0 sites20 target enrollmentStarted: August 28, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) History of other malignancy,except for curatively treated carcinoma in situ or intramucosal carcinoma (Subjects with other malignancies who have been disease-free for at least 5 years are eligible.) (2) Patients who have undergone radiotherapy (3) Patients with diarrhea (4) Patient with regular use of furucytocin (5) Patients with severe complications,(severe cardiovascular disease,severe heart disease,heart failure,liver failure,renal failure or uncontrollable diabetes mellitus) (6) Patients with uncontrollable ascites and pleural effusion (7) The case suspected of infection with feaver (over 38 centigrade). (8) Serious drug hypersensitivity (9) Patients with paralytic ileus, bowel obstruction (10) Women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. (11) Any other cases who are regarded as inadequate for study enrollmet by investigators
Investigators
Similar Trials
Completed
Phase 2
A phase II study of preoperative concurrent chemoradiotherapy with TS-1/ Oxaliplatin in patients with locally advanced rectal cancer(PerSeUS-RC01)locally advanced rectal cancerJPRN-UMIN000011861PerSeUS:Perpetual Study estimated-by United Sections in Gifu40
Recruiting
Phase 2
A phase II study of preoperative concurrent chemoradiation therapy for patients with locally advanced rectal cancerectal cancerJPRN-UMIN000004104Hamamatsu University School of Medicine, Second department of Surgery30
Completed
Phase 2
A phase II study of preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancerresectable locally advanced non small cell lung cancerJPRN-UMIN000000599Setouchi Lung Cancer Group1
Active, not recruiting
Phase 1
Multicenter phase II study of preoperative chemoradiotherapy with CApecitabine plus Temozolomide in patients with MGMT silenced and microsatellite stable locally Advanced RecTal Cancer: the CATARTIC triallocally advanced rectal cancer (LARC)MedDRA version: 20.0Level: HLTClassification code: 10010023Term: Colorectal neoplasms malignant Class: 10029104CTIS2024-513931-26-00Fondazione IRCCS Istituto Nazionale Dei Tumori21
Active, not recruiting
Phase 1
Study on the association of radiotherapy with capecitabine and temozolomide followed by surgery in patients with locally advanced rectal cancerEUCTR2021-002325-18-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI21